Please note:
Investing in early stage businesses involves risks, including illiquidity, lack of dividends, loss of investment and dilution, and it should be done only as part of a diversified portfolio. This platform is targeted solely at investors who are sufficiently sophisticated to understand these risks and make their own investment decisions. Investors are encouraged to review and evaluate the investments and determine at their own discretion, the appropriateness of making the particular investment. The information on this website is provided for informational purposes only, but we cannot guarantee that the information is accurate or complete. We strongly encourage investors to complete their own due diligence with licensed professionals, prior to making any investment and will not offer any legal or tax advice.
Short Summary
Herstellungsbetrieb für Zytostatika und parenterale Zubereitungen sowie Verblisterung von Arzneimitteln.
Highlights
- Pharmabranche
- Feste Kunden vorhanden
- Sehr gute Rendite
Overview
Target | 90,000,000 |
Minimum | 100,000,000 |
Investment Raised | 0 |
Previous Rounds | 0 |
Stage | Breaking Even |
Investor Role | Any |
The Team
Wir bestehen aus allen notwendigen für das vorhaben notwendigen Personalresourcen.
The Deal
Looking for PKR 924,000,000 - Min per Investor PKR 154,000,000 Bitte treten Sie mit uns in Kontakt für weitere Details zu dem vorliegenden Angebot.